UBS analyst David Dai raised the price target on Nuvalent (NASDAQ: NUVL) to $114.00 (from $100.00) while maintaining a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE